This partnership strengthens LMS as a leading CDMO supplier of peptide materials for both innovator and generic markets
Biocon will acquire the residual stake held by Mylan (Viatris) for a total consideration of US$ 815 million
Ascelis Center of Excellence for Peptide Development and Characterization will drive the development of cosmetic, therapeutic, and pharmaceutical peptides
India's pharmaceutical sector is rapidly shifting from a generics-led foundation to an innovation-driven ecosystem
Syngene International has reported total income of Rs. 926 crore during the period ended September 30, 2025
Accelerating hit-to-lead timelines, and strengthening end-to-end drug discovery and development services
PeptiGlow features premium-grade hydrolyzed collagen peptides that support skin elasticity and hydration
IMCD engaged with manufacturers, formulators, and brand leaders, offering valuable insights into evolving consumer trends
A Post Graduate in Science faculty and has a wide experience spanning over 35 years in the field of manufacturing Bulk Drugs and Active Pharmaceutical Intermediaries
Ascletis announces ultra-long-acting subcutaneous depot maintenance formulation of small molecule GLP-1R agonist ASC30 with 75-Day observed half-life in participants with obesity
Subscribe To Our Newsletter & Stay Updated
